MITO 32
Randomized phase II randomized trial on Letrozole vs clinician’s choice chemotherapy in heavily pretreated recurrent ovarian, primary peritoneal or fallopian tube cancers
STATO: Ongoing
PATOLOGIA: Ovaio
CENTRO COORDINATORE MITO:
PRINCIPAL INVESTIGATOR: Claudia Marchetti
CO INVESTIGATOR: -
STUDY COORDINATOR: -